Current Drug Discovery Technologies

Editor-in-Chief:
Vladimir P. Torchilin
Department of Pharmaceutical Science Center
for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA

 

Back

Become EABM
Become Reviewer

Meet Our Editor promotion: free to download

Volume:13   Issue: 2
Pp: 58-59
Vladimir Torchilin
DOI: 10.2174/157016381302160623143936

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma open access plus

Volume:13   Issue: 2
Pp: 68-76
Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall and John Abisheganaden
DOI: 10.2174/1570163813666160524142846

Development and Assessment of a Gas Chromatographic Based Method for the Quantification of Thymol from Cream Based Formulation

Volume:13   Issue: 2
Pp: 77-83
Soliman Mohammadi Samani, Mahmoodreza Moein, Peyman Petramfar and Mohammad M. Zarshenas
DOI: 10.2174/1570163813666160519111145


Quantitative Structure-Cytotoxic Activity Relationship 1-(Benzoyloxy)urea and Its Derivative open access plus

Volume:13   Issue: 2
Pp: 101-108
Suko Hardjono, Siswandono Siswodihardjo, Purwanto Pramono and Win Darmanto
DOI: 10.2174/1570163813666160525112327

Imidazolium Ionic Liquids as Potential Anti-Candida Inhibitors: QSAR Modeling and Experimental Studies

Volume:13   Issue: 2
Pp: 109-119
Diana Hodyna, Vasyl Kovalishyn, Sergiy Rogalsky, Volodymyr Blagodatnyi and Larisa Metelytsia
DOI: 10.2174/1570163813666160510122201